Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
abbvie
alzheimer's disease
amgen
biotech
boston blog main
boston top stories
boulder/denver blog main
boulder/denver top stories
cystic fibrosis
deals
detroit blog main
detroit top stories
diagnostics
gilead sciences
indiana blog main
indiana top stories
life sciences
2
×
merck
2
×
national
national blog main
2
×
national top stories
new york blog main
new york top stories
novartis
pfizer
raleigh-durham blog main
raleigh-durham top stories
san diego blog main
san diego top stories
san francisco blog main
san francisco top stories
seattle blog main
seattle top stories
startups
texas blog main
texas top stories
wisconsin blog main
wisconsin top stories
adverum biotechnologies
albert bourla
What
acquisitions
biggest
bio
ceo
2
×
drug
roundup
albert
bourla
build
buy
company
company’s
crispr
daniel
debut
dyne’s
future
gilead
imports
maker
maps
measured
microbiome
moves
openly
o’day
patients
pfizer
pfizer’s
pipeline
revenue
sciences
scores
seagen
spoken
today
way
week
world’s
Language
unknown
unset
Current search:
merck
×
" life sciences "
×
ceo
×
" national blog main "
×
@xconomy.com
4 years ago
Bio Roundup: SeaGen Scores, Dyne’s Debut, Microbiome Moves & More
@xconomy.com
5 years ago
Bio Roundup: Pfizer’s Future, CRISPR in Patients, Drug Imports & More